Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35553290)
Watch
English
Controversies in iron management
scientific article published on November 1, 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Controversies in iron management
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
main subject
nephrology
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
author name string
Chaim Charytan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
Allen R. Nissenson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531776
retrieved
19 March 2024
language of work or name
English
1 reference
stated in
National Center for Biotechnology Information
PubMed ID
14531776
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14531776
retrieved
19 March 2024
publication date
1 November 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
full work available at URL
http://www.kidney-international.org/article/S0085253815496450/pdf
file format
Portable Document Format
online access status
open access
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531776
retrieved
19 March 2024
https://api.elsevier.com/content/article/PII:S0085253815496450?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
https://api.elsevier.com/content/article/PII:S0085253815496450?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
published in
Kidney International. Supplement
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
issue
87
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
page(s)
S64-71
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
cites work
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
series ordinal
1
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis
series ordinal
3
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Iron sucrose: the oldest iron therapy becomes new.
series ordinal
4
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Just the FAQs: frequently asked questions about iron and anemia in patients with chronic kidney disease
series ordinal
5
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Parenteral iron safety and the special article "Just the FAQs: frequently asked questions about iron and anemia in patients with chronic kidney disease"
series ordinal
6
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Safety issues with iron sucrose
series ordinal
7
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Oral iron absorption in hemodialysis patients treated with erythropoietin
series ordinal
8
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
series ordinal
9
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
A randomized controlled study of iron supplementation in patients treated with erythropoietin
series ordinal
10
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients
series ordinal
13
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Clinical studies of hip: An oral heme-iron product
series ordinal
14
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Iron absorption from the whole diet in men: how effective is the regulation of iron absorption?
series ordinal
15
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
The safety of intravenous iron dextran in hemodialysis patients
series ordinal
17
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans
series ordinal
18
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran
series ordinal
19
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration
series ordinal
21
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Intravenous iron sucrose: establishing a safe dose
series ordinal
22
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Acute iron poisoning. A review
series ordinal
24
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients
series ordinal
25
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion
series ordinal
28
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Non-transferrin-bound iron during allogeneic stem cell transplantation
series ordinal
29
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury
series ordinal
30
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration
series ordinal
31
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients
series ordinal
32
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload
series ordinal
33
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Intravenous ascorbic acid in haemodialysis patients with functional iron deficiency
series ordinal
35
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Erythropoietin and iron: the role of ascorbic acid
series ordinal
36
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients
series ordinal
37
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
IRON METABOLISM IN SCURVY WITH SPECIAL REFERENCE TO ERYTHROPOIESIS.
series ordinal
38
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration.
series ordinal
39
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients
series ordinal
41
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
A randomized trial of iron deficiency testing strategies in hemodialysis patients
series ordinal
43
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
series ordinal
44
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients
series ordinal
45
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
series ordinal
46
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients
series ordinal
47
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients?
series ordinal
48
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure
series ordinal
49
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients
series ordinal
51
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial
series ordinal
52
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial
series ordinal
53
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Error, not iron, generates cytotoxicity
series ordinal
58
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo
series ordinal
59
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients
series ordinal
60
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Safety issues with iron sucrose
series ordinal
62
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients.
series ordinal
64
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients
series ordinal
65
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)
series ordinal
67
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Iron overload and mobilization in long-term hemodialysis patients
series ordinal
68
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Erythropoietin treatment in haemodialysis patients with iron overload
series ordinal
69
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Effect of iron on leukocyte function: inactivation of H2O2 BY IRON
series ordinal
70
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Impact of iron dextran on polymorphonuclear cell function among hemodialysis patients.
series ordinal
71
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment
series ordinal
73
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.
series ordinal
76
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients.
series ordinal
77
1 reference
stated in
Crossref
DOI
10.1046/J.1523-1755.64.S87.10.X
reference URL
https://api.crossref.org/works/10.1046/J.1523-1755.64.S87.10.X
retrieved
19 March 2024
Identifiers
DOI
10.1046/J.1523-1755.64.S87.10.X
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
PubMed ID
14531776
1 reference
stated in
Europe PubMed Central
PubMed ID
14531776
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531776%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit